Pfizer Ophthalmics

• Go to www.pfizer.com

Pfizer is a SILVER level sponsor of the American Optometric Association.

Pfizer Ophthalmics is committed to preserving sight and eliminating preventable blindness in the United States and globally. Pfizer discovers, develops and provides leading treatments to support patients who are at risk of blindness or suffering from vision impairment and is dedicated to serving the health care professionals who treat people with eye disorders.

Karen Fixler, U.S. Marketing Team Leader at Pfizer Ophthalmics said, “Pfizer Ophthalmics is committed to developing and partnering with others to develop effective tools and treatments for eye care professionals and patients who are served by them.”

Over the past few years, Pfizer Ophthalmics has initiated strategic partnerships with biotechnology companies, universities, hospitals and non-profit organizations in addition to collaborating with its internal research and development team to discover scientific approaches to accelerate the science of the treatment and care of eye diseases.

“Pfizer recognizes the important role that optometrists play in the diagnosis and management of eye diseases. We are excited to be a part of the American Optometric Association’s Ophthalmic Council™ and look forward to collaborating on the 2010 glaucoma patient education initiative,” said Ms. Fixler.”

In addition, Pfizer Ophthalmics has many resources available to support eye care health professionals in the management of glaucoma including a website designed specifically for optometrists. The company is also taking an active role in helping to improve the dialogue between physicians and patients to address adherence barriers through the “i2i: Conversations to Enhance Adherence” educational initiative (www.i2iadherence.com). Pfizer also supports optometric-centered educational programming in partnership with the National Glaucoma Society and the Optometric Glaucoma Society.

“Pfizer is committed to the ophthalmics therapeutic area, and will continue to invest and collaborate with healthcare professionals, corporations, advocacy organizations and the patient community to fight eye diseases,” added Ms. Fixler.

For more information about Pfizer and its products, please visit www.Pfizer.com.